Search Results 611-620 of 18111 for monoclonal antibody
Nivolumab is a monoclonal antibody that affects the immune system and helps control the growth of cancer cells. This medicine is to be given only by or ...
De Novo Glomerulonephritis with Chronic Antibody Mediated Rejection in a ... Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk ...
Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...
Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
The extraordinary mutation of the Omicron variant has caused us to lose two sets of monoclonal antibodies, leaving us with one monoclonal antibody for ...
... monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent) that did not work well. Melphalan flufenamide belongs to the group of medicines ...
RO7790121 is a fully human immunoglobulin G1 monoclonal antibody (mAb) against tumor necrosis factor-like ligand 1A (TL1A). TL1A plays a central role in the ...
Monoclonal antibody treatment can help high-risk patients with COVID-19 featured image. Featured News. Monoclonal antibody treatment can help high-risk ...
Trastuzumab emtansine is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug called emtansine. Trastuzumab attaches to HER2 positive ...
Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.